Andrés Cervantes

Research interests

Publications

• The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

  ESMO Open · 2023 · https://doi.org/10.1016/j.esmoop.2023.101567

• Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.07.003

• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.10.003

• Clinical management of metastatic colorectal cancer in the era of precision medicine

  CA A Cancer Journal for Clinicians · 2022 · https://doi.org/10.3322/caac.21728

• Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30555-6

• Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30027-0

• Integration of oncology and palliative care: a Lancet Oncology Commission

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30415-7

• Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy308

• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx224

• Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx175

• Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx738

• ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

  Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw235

• Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2016 · 10.1093/annonc/mdw350

• Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00086-8

• Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2014 · 10.1093/annonc/mdu260

• Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt342

• First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

  Cancer Discovery · 2013 · 10.1158/2159-8290.cd-12-0429

• EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

  European Journal of Cancer · 2013 · https://doi.org/10.1016/j.ejca.2013.06.048

• Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt354

• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

  Annals of Oncology · 2012 · 10.1093/annonc/mds236

• Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

  International Journal of Gynecological Cancer · 2011 · https://doi.org/10.1097/igc.0b013e3182070f17

• A Phase 3 Trial of Bevacizumab in Ovarian Cancer

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103799

• Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.27.6055

• Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2010 · 10.1093/annonc/mdq164

• OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.03.0106

• Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043116

• Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

  Journal of Clinical Oncology · 2000 · https://doi.org/10.1200/jco.2000.18.16.2938

Current projects

No projects listed.